Intravenous thrombolysis in the emergency department for the treatment of acute ischaemic stroke

Emergency Medicine Journal

Volumn 25, Issue 7, 2008, Pages 403-406

  Semplicini, Andrea ^a   Benetton, V ^a   Macchini, L ^a   Realdi, A ^a   Manara, R ^a   Carollo, C ^a   Parotto, E ^a   Mascagna, V ^a   Leoni, M ^a   Calo L A ^a   Pessina, A C ^a   Tosato, F ^a  

^a UNIVERSITY OF PADUA MEDICAL SCHOOL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE;

ACUTE DISEASE; AGED; ARTICLE; BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; COMPUTER ASSISTED TOMOGRAPHY; EMERGENCY PHYSICIAN; EMERGENCY WARD; FAMILY; FEMALE; GINGIVA BLEEDING; HUMAN; INFORMED CONSENT; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MORTALITY; PATIENT TRANSPORT; PILOT STUDY; PRIORITY JOURNAL; REHABILITATION CARE; SYMPTOM;

AGED; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; EMERGENCY SERVICE, HOSPITAL; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; INFUSIONS, INTRAVENOUS; INTENSIVE CARE; MAGNETIC RESONANCE IMAGING; MALE; STROKE; TISSUE PLASMINOGEN ACTIVATOR; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 47549087214     PISSN: 14720205     EISSN: None     Source Type: Journal    
DOI: 10.1136/emj.2007.053033     Document Type: Article

References (12)

1. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333:1581-7.
2. Schumacher HC, Bateman BT, Boden-Albala B, et al. Use of thrombolysis in acute ischemic stroke: analysis of the Nationwide Inpatient Sample 1999 to 2004. Ann Emerg Med 2007; 50:99-107.
3. Wahlgren N, Ahmed N, Davalos A, et al. Thrombolysis wth alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study. Lancet 2007;369:275-82.
4. Adams HP Jr, Adams RJ, Brett T, et al, Stroke Council of the American Stroke Association. Guidelines for the early management of patients with ischemic stroke: a scientific statement from the Stroke Council of the American Stroke Association. Stroke 2003; 34:1056-83.
5. Semplicini A, Calò L. Administering antihypertensive drugs after acute ischemic stroke: timing is everything. Can Med Assoc J 2005;172:625-6.
6. Fiorelli M, Bastianello S, von Kummer R, et al. Hemorrhagic transformation within 36 hours of a cerebral infarct: relationships with early clinical deterioration and 3-month outcome in the European Cooperative Acute Stroke Study I (ECASS I) cohort. Stroke 1999; 30:2280-4.
7. Abel-Smith B, Mossialos E. Cost containment and health care reform: a study of the European Union. Health Policy 1994; 28:89-132.
8. Wiegand N, Luthy B, Vogel B, et al. Intravenous thrombolysis for acute ischaemic stroke in a hospital without a specialised neuro-intensive care unit. Swiss Med Wkly 2004; 134:14-17.
9. The NINDS t-PA Stroke Study Group. Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke. Stroke 1997; 28:2109-18.
10. Brott T, Lu M, Kothari B, Fagan SC, et al. Hypertension and its treatment in the NINDS rt-PA Stroke Trial. Stroke 1998; 29:1504-9.
11. Adams HP Jr, del Zoppo G, Alberts MJ, et al. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association, Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups. Stroke 2007;38:1655-711.
12. Audebert HJ, Kukla C, Clarmann von Claranau S. et al. Telemedicine for safe and extended use of thrombolysis in stroke: the Telemedic Pilot Project for Integrative Stroke Care (TEMPiS) in Bavaria. Stroke 2005;36:287-91.